NEW:

Cybersecurity Learning Bundle
Menu +

Resource Details

Menu

Babies Born With Congenital Syphilis: What Happens Next?

Year Developed: 2024

Resource Type: Archived Webinar.

Primary Audience: C-Suite (CEOs, CFOs, CIO, COOs, CMOs, etc.) Clinicians
Secondary Audience: PCAs

Language(s): English

Developed by: Renaye James Healthcare Advisors (RJHA) (See other resources developed by this organization).

Resource Summary: Congenital syphilis cases are on the rise. The transmission of spirochete Treponema pallidum from a pregnant individual to a fetus is the main method of infection. Evaluation for congenital syphilis is warranted in all infants born to mothers who have reactive nontreponemal and treponemal tests for syphilis during pregnancy

Resource Details: If the evaluation identifies an infant as a proven, highly probable, or possible disease, treatment with Penicillin G is recommended. After treatment, the pediatric patient requires continued evaluation in the form of physical examinations, developmental and hearing screenings, and frequent serologic tests (i.e., nontreponemal tests). Source: CDC. (2023). U.S. Syphilis Cases in Newborns Continue to Increase: A 10-Times Increase Over a Decade. https://www.cdc.gov/media/releases/2023/s1107-newbornsyphilis.html#: Hussain SA, Vaidya R. Congenital Syphilis. [Updated 2023 Aug 8]. In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK537087

Resource Topic: Quality, Special and Vulnerable Populations

Resource Subtopic: Patient Safety, Policy and Advocacy.

Keywords: Access to Care, Care Coordination, Chronic Diseases and Care, Education of - Staff (e.g., Competency-Based), Health Risk and Behavior, Infants, Toddlers, and Children (Pediatrics), Team-Based Care.

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,625,000 with 0 percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.